MedPath

Desflurane and Brain Relaxation in Craniotomy

Not Applicable
Completed
Conditions
Supratentorial Tumor
Interventions
Registration Number
NCT04691128
Lead Sponsor
Beijing Tiantan Hospital
Brief Summary

Optional brain relaxation improves the surgeon's operating conditions and is likely to minimize the degree of retraction injury ,with the potential for providing patients with a better outcome. The choice of anesthetic drugs can affect intraoperative brain relaxation. Propofol suppresses brain metabolism, reduces cerebral blood flow, and provides satisfactory brain relaxation. Desflurane is often criticized in neurosurgery due to its cerebral vasodilation and potential to increase intracranial pressure, however, it has been found to have a little clinical significance. This study intends to compare the effects of desflurane with propofol on brain relaxation in patients with supratentorial tumors under mild hyperventilation, and to provide new clinical evidence for the use of desflurane in neurosurgical anesthesia.

Detailed Description

To compare the effect of desflurane versus propofol combined with remifentanil anesthesia on brain relaxation in patients undergoing supratentorial tumor surgery with mild hyperventilation, and compare the emergence time and common complications during recovery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
111
Inclusion Criteria
  • 18-60 years
  • Scheduled for elective craniotomy for supratentorial cerebral tumors
  • ASA status I-III
  • Glasgow score of 15
  • No clinical signs of intracranial hypertension
  • Preoperative brain imaging (CT or MRI) with midline shift less than 5mm
  • Informed consent signed by patients
Exclusion Criteria
  • Scheduled intraoperative motor evoked potential monitoring
  • Patients with cerebral vascular diseases
  • Uncontrolled cardiopulmonary disease
  • Schedule to retain tracheal intubation after surgery
  • Unable to comprehend and cooperate with the examination
  • BMI > 30 Kg/m-2
  • Emergency surgery
  • History of related anesthetic allergy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Desflurane inhalational anesthesiaDesflurane-
Propofol total intravenous anesthesiaPropofol-
Primary Outcome Measures
NameTimeMethod
Proportion of satisfactory brain relaxationduring surgery

Assessed by the neurosurgeon using a 4-point scale (1= perfectly relaxed, 2= satisfactorily relaxed, 3= firm brain, 4=bulging brain) at the opening of the dura mater, score 1 and 2 represent satisfactory brain relaxation

Secondary Outcome Measures
NameTimeMethod
Dural tensionduring surgery

evaluated using a 4-point scale after bone flap removal.

Quality of anesthesia recoveryat postoperative day 1

assessed by quality of recovery-15 scale (QoR-15)

Early postanesthesia cognitive recoveryat 15, 30min after tracheal extubation

evaluated by Short Orientation Memory Concentration Test (SOMCT)

Emergence timefrom drug discontinuation to eye opening, assessed up to 1 hours

from drug discontinuation to eye opening

Postoperative complicationsfrom drug discontinuation to discharge from PACU (Postanesthesia care unit), assessed up to 3 hours

incidence of hypoxemia, hypotension, hypertension, tachycardia, bradycardia, agitation, shivering.

Duration in PACU (Postanesthesia care unit)from entering PACU to exiting PACU, an expected average of 1 hour

time from entering PACU to exiting PACU

Anesthesia expensesat postoperative day 1

Total cost of anesthesia

Extubation timefrom drug discontinuation to tracheal extubation, assessed up to 1 hours

from drug discontinuation to tracheal extubation

Postoperative pain and postoperative nausea and vomiting (PONV)during the PACU stay and postoperative day 1.

evaluated by Visual Analogue Score(VAS).

Trial Locations

Locations (1)

Beijing Tiantan Hospital, Capital Medical University

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath